|
|
???tair.name??? >
???browser.page.title.author???
|
"lin zu yau"???jsp.browse.items-by-author.description???
Showing items 1-23 of 23 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 嘉南藥理大學 |
2021 |
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
|
Yeh, Ming-Lun; Kuo, Hsing-Tao; Huang, Ching-, I; Huang, Chung-Feng; Hsieh, Ming-Yen; Liang, Po-Cheng; Lin, I-Hung; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Dai, Chia-Yen; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long |
| 國立交通大學 |
2020-10-05T02:02:03Z |
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection
|
Liang, Po-Cheng; Tsai, Pei-Chien; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Chung, Raymond T.; Yu, Ming-Lung; Tsai, Yi-Shan; Hsieh, Meng-Hsuan; Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-, I; Holmes, Jacinta A. |
| 國立交通大學 |
2020-10-05T01:59:45Z |
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication
|
Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Ching-, I; Lee, Hsiang-Chun; Lai, Wen-Ter; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2020-07-01 |
Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C
|
Yu, Ming-Lung; Dai, Chia-Yen; Chuang, Wan-Long; Tsai, Yi-Shan; Yeh, Ming-Lun; Tsai, Pei-Chien; Huang, Ching-, I; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Liu, Ta-Wei; Lin, Yi-Hung; Liang, Po-Cheng; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu |
| 國立交通大學 |
2020-05-05T00:02:21Z |
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy
|
Yu, Ming-Lung; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Huang, Ching-, I; Yeh, Ming-Lun; Wang, Shu-Chi; Lin, Yi-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Ko, Yu-Min; Tsai, Yi-Shan; Chen, Kuan-Yu; Lin, Ching-Chih; Tsai, Pei-Chien; Liu, Ta-Wei; Hsu, Po-Yao; Hsu, Cheng-Ting; Jang, Tyng-Yuan; Wei, Yu-Ju |
| 國立交通大學 |
2019-12-13T01:09:55Z |
Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents
|
Jang, Tyng-Yuan; Huang, Ching-, I; Yeh, Ming-Lun; Liang, Po-Cheng; Tsai, Pei-Chien; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-12-13T01:09:55Z |
Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Liang, Po-Cheng; Lin, Yi-Hun; Hsieh, Ming-Yen; Chen, Kuan-Yu; Ko, Yu-Min; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-08-02T02:18:36Z |
Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C
|
Batsaikhan, Batbold; Lu, Ming-Ying; Yeh, Ming-Lun; Huang, Ching-, I; Huang, Chung-Feng; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Hsieh, Ping-Hsin; Chuang, Wan-Long; Lee, Jin-Ching; Yu, Ming-Lung; Dai, Chia-Yen |
| 國立交通大學 |
2019-08-02T02:18:29Z |
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Wei, Yu-Ju; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T06:01:07Z |
Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication
|
Huang, Chung-Feng; Wang, Shu-Chi; Yeh, Ming-Lun; Huang, Ching-I; Tsai, Pei-Chien; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Angela; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T06:00:31Z |
Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Chen, Jyh-Jou; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:55Z |
Association of hyperuricemia with disease severity in chronic hepatitis C patients
|
Jang, Tyng-Yuan; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Hsieh, Meng-Hsuan; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:49Z |
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection
|
Huang, Chung-Feng; Wang, Shu-Chi; Chang, Wen-Tsan; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Chuang, Wan-Long; Huang, Jee-Fu; Dai, Chia-Yen; Chen, Yao-Li; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:10Z |
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng;Yu, Ming-Lung;Kao, Jia-Horng;Tseng, Tai-Chung;Yeh, Ming-Lun;Huang, Jee-Fu;Dai, Chia-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Wang, Liang-Yen;Juo, Suh-Hang Hank;Chuang, Wan-Long;Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Yu, Ming-Lung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; Yeh, Ming-Lun; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Chuang, Wan-Long; Liu, Chen-Hua; Liu, Chen-Hua |
| 臺大學術典藏 |
2018-09-10T09:14:10Z |
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Re, Valli De; CHEN-HUA LIU; Yu, Ming-Lung; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; RE, Valli DE |
| 國立交通大學 |
2018-08-21T05:53:33Z |
Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立成功大學 |
2015-09-15 |
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers
|
Chi, Jhih-Ying; Hsiao, Yu-Wei; Li, Chien-Feng; Lo, Yu-Chih; Lin, Zu-Yau; Hong, Jhen-Yi; Liu, Yang-Ming; Han, Xiu; Wang, Shao-Ming; Chen, Ben-Kuen; Tsai, Kelvin K.; Wang, Ju-Ming |
| 國立臺灣大學 |
2013 |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng; Yu, Ming-Lung; Kao, Jia-Horng; Tseng, Tai-Chung; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Liu, Chen-Hua; 劉振驊; 高嘉宏 |
| 嘉南藥理大學 |
2012-05 |
Erratum to:"Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin"[J Hepatol 2012;56:34–40]
|
Huang, Chung-Feng; Huan, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 嘉南藥理大學 |
2012 |
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
|
Huang, Chung-Feng; Huang, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 國立臺灣大學 |
2012 |
Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2011 |
Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses
|
葉明倫; 洪肇宏; 劉俊人; 李全謨; 王景弘; 林子堯; 盧勝男; 胡琮輝; 余明隆; 高嘉宏; 莊萬龍; 陳培哲; 陳定信; YEH, MING-LUN; HUNG, CHAO-HUNG; LIU, CHUN-JEN; LEE, CHUAN-MO; WANG, JING-HOUNG; LIN, ZU-YAU; LU, SHENG-NAN; HU, TSUNG-HUI; YU, MING-LUNG; KAO, JIA-HORNG; CHUANG, WAN-LONG; CHEN, PEI-JER; CHEN, DING-SHINN |
Showing items 1-23 of 23 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
